![Amir Safavi: How to improve the safety of SABR for ultra central thoracic tumors?](https://oncodaily.com/pub/uploads/2024/08/WhatsApp-Image-2024-08-27-at-13.43.28_5e713b20.jpg)
Aug 31, 2024, 17:06
Amir Safavi: How to improve the safety of SABR for ultra central thoracic tumors?
Amir Safavi, Radiation Oncology Fellow at Memorial Sloan Kettering Cancer Centre ,shared a post on X:
“Risk mitigation strategies for ultracentral lung tumors in IJROBP – The Red Journal:
- Moderate plan dmax (eg 110-120%).
- Limit OAR hotspots (esp Esophagus).
- Avoid overly generous PTV.
- Nodes treated cooler (eg 35/5) Accurate target and OAR contouring (use contrast).“Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral Thoracic Tumors?Authors: Amir H. Safavi, David A. Palma and
Source: Amir Safavi/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023